K252484

Substantially Equivalent

cobas HCV

Applicant: Roche Molecular Systems, Inc.
Product code: MZP
Advisory panel: Microbiology
Date received: 2025-08-07
Decision date: 2025-11-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.